Lebanon vs South-East Asia (WHO region): HIV-positive TB patients on ART (antiretroviral therapy)
Lebanon
100.0%
in 2024
South-East Asia (WHO region)
94.0%
in 2024
Lebanon rank
1st
South-East Asia (WHO region) rank
4th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Lebanon
- South-East Asia (WHO region)
How they compare
Lebanon currently reports 100.0% against 94.0% in South-East Asia (WHO region), a difference of 6.0%.
That makes Lebanon's figure about 1.1 times South-East Asia (WHO region)'s.
The two have swapped places 6 times across 17 shared years of data; in 2007 it was Lebanon ahead.
Lebanon ranks 1st and South-East Asia (WHO region) ranks 4th of 144 countries.
Lebanon has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Lebanon | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 36.0% | 64.0% | Lebanon |
| 2010s | 88.5% | 76.0% | 12.5% | Lebanon |
| 2020s | 91.8% | 91.8% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Lebanon or South-East Asia (WHO region)?
- Lebanon, at 100.0% against 94.0% in South-East Asia (WHO region) as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Lebanon and South-East Asia (WHO region)?
- 6.0%, with Lebanon ahead.
- How many years of comparable data are there for Lebanon and South-East Asia (WHO region)?
- 17 years are reported by both, from 2007 to 2024.
- How do Lebanon and South-East Asia (WHO region) rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Lebanon ranks 1st and South-East Asia (WHO region) ranks 4th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.